Mariana Sprincean

Mariana Sprincean

Auto-generated profile, based on publicly available information

Mariana Sprincean

State University of Medicine and Pharmacy „Nicolae Testemiţanu”, Chisinau, Republic of Moldova

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2019 in Biological Markers in Fundamental and Clinical Medicine (collection of abstracts)
Verified
Journal Article
Open access
PDF file
MSM. Sprincean
M. Sprincean
HHH. Hadjiu
H. Hadjiu
CCC. Calcii
C. Calcii
NLN. Lupusor
N. Lupusor
CGC. Griu
C. Griu
NRNinel Revenco
Ninel Revenco
VASCULAR ENDOTHELIAL GROWTH FACTOR: AN IMPORTANT BIOMARKER IN PEDIATRIC ISCHEMIC STROKE

1 December 2025 in Moldovan Journal of Health Sciences
Verified
Journal Article
Closed access
SRStela Racovita
Stela Racovita
VMVeaceslav Mosin
Veaceslav Mosin
SCSvetlana Capcelea
Svetlana Capcelea
AMAna Misina
Ana Misina
VRVasile Racovita
Vasile Racovita
MSMariana Sprincean
Mariana Sprincean
Introduction. Male infertility has a heterogeneous etiology, most commonly caused by disorders of spermatogenesis, clinically manifested as azoospermia or severe oligospermia. Genetic factors account for approximately 30% of male infertility cases associated with azoospermia. This high frequency is due to the involvement of numerous genes in the regulation of sexual development and reproduction. Among the various genetic causes of spermatogenic failure, chromosomal abnormalities are among the most clinically significant. The objective of the study was to evaluate the profile of chromosomal variations in infertile men with azoospermia, to optimize assisted reproductive strategies in infertile couples. Material and methods. A group of 96 azoospermic men underwent karyotype analysis. The diagnosis of azoospermia was established based on at least two consecutive semen analyses performed according to the guidelines of the World Health Organization (WHO). Cytogenetic analysis was carried out on peripheral blood lymphocytes, with results interpreted according to the 2016 International System for Human Cytogenetic Nomenclature (ISCN). Hormonal profiles (FSH, LH, prolactin, testosterone) were correlated with chromosomal findings. Statistical analysis was performed using SPSS (Statistical Package for the Social Sciences), version 22.0. Results. Cytogenetic investigations in azoospermic patients (n = 96) revealed karyotype variations in 25.0% of cases, including sex chromosome abnormalities in 16.7%: 47,XXY - Klinefelter syndrome (11.5%); microscopic structural variations of the Y chromosome (2.1%); and single cases of 47,XYY - Jacobs syndrome; 46,XX male - sex reversal; and 45,X/46,XY - mixed gonadal dysgenesis. Autosomal abnormalities were found in 8.3% of cases: translocations (3.1%), inversions (2.1%), chromosomal polymorphisms (2.1%), and one case with 46,XY,fra(17)(p12). Patients with sex chromosome abnormalities exhibited significantly higher FSH and LH levels compared to those with autosomal abnormalities (p less than 0.05), whereas prolactin and testosterone levels did not differ significantly between the groups. Conclusions. The high prevalence of chromosomal abnormalities in azoospermic men supports the inclusion of cytogenetic testing in the routine evaluation of male infertility. Identifying the type of chromosomal defect allows for appropriate genetic counseling and aids in decision-making regarding assisted reproductive options.

6 June 2017
Verified
Conference Paper
Closed access
PDF file
HSHadjiu Svetlana
Hadjiu Svetlana
CCCalcii Cornelia
Calcii Cornelia
SMSprincean Mariana
Sprincean Mariana
LNLupusor Nadejda
Lupusor Nadejda
RNRevenco Nineli
Revenco Nineli
Introduction Epilepsy (EP) is one of the entities that are developing in children withperinatal brain lesions (PBL). An early and accurate diagnosis of EP is important because EP has major socioeconomic consequences for both the individual patient and society. The purpose of the study:we aimed toelucidate the significance of perinatal brain damage in childhood epilepsy. Research methodology we performed a longitudinal prospective case-control study of 1036 children with PBL withvarious degrees of severity, followedbetween the age of 1–3 months and 48±12 months. Two hundred and fifty-ninechildren from study group (25%; 95CI23,65–26,35)developed EP. The control group included 334 healthy children. EEG examination and MRI brain imaging was performed. Enzyme-linked Immunosorbent Assay (ELISA) was used to assess the concentrations of brain derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) in the serum in all children. Statistical analyses were obtained using Statistics 7.0 software (StatSoftInc) and Excel. Results: Of all cases of EP- 211 (81,47%; 95 CI 79,06–83,88) were generalised forms; 48 (18,5±2,41%; 95CI16,09–20,91)– focalforms. In 89 cases (34,4%; 95CI31,45–37,35) neonatal seizures preceded EP, in the rest 234 cases (90.3% 95 CI 88.47 to 92.13) EP started at infant age, preferentially between 3 and 6 months – 89 (34,4%; 95CI31,45–37,35). We obtained strong correlations between imaging examinations andpharmacoresistant EP (rxy=-0,72)and middle correlations (rxy=-0,53) with controlled EP. EEG changes comprised approximately 9–11 types of routes and have correlated with the type of seizures (rxy=-0,72). Some patterns (isolated slow activity, diffuse slow activity, grouped generalised peaks) werepreceding the epileptiformchanges(rxy=-0,42).The observedcorrelations between low absoluteserum levels of neurotrophic factors(NF) (at 1–3 months) and EEG changes: BDNF (rxy=-0,72) andCNTF (rxy=-0,74), suggestthe development of pharmacoresistant EP and its progress to epileptic encephalopathies with sever neurophysiological processes disturbance. Conclusions PBL has an important role in child EP. EP is associated withstructural brain abnormalities, variable electroencephalographic changes that strongly correlate with NF deficit, suggesting a reserved prognosis and evolution towards epileptic encephalopathies. NF study allowed the understanding of the pathogeneticaspects of EP, thus forming the basis for the potential neuroprotective strategies and the need for future studies.

6 June 2017
Verified
Conference Paper
Closed access
PDF file
HSHadjiu Svetlana
Hadjiu Svetlana
CCCalcii Cornelia
Calcii Cornelia
SMSprincean Mariana
Sprincean Mariana
LNLupusor Nadejda
Lupusor Nadejda
RNRevenco Nineli
Revenco Nineli
Background Paediatric stroke is a neurological injury that can lead to significant morbidity and mortality. Stroke remains among the top 10 causes of death in children and its morecommon causes are cardiac disorders, blood disorders, vasculopathiesand metabolic disorders. Aim We aim to describe two clinical cases of different diseases, wherestroke was the first manifestation. Material and methods wepresenttwo clinical cases: (1) a2-year-old girl diagnosed with MELAS syndrome and (2) a 14-year-old girl of with systemic lupus erythematosus (SLE), both patients with clinical signs of stroke. Results The 2-year-old patientwas admitted in our clinic with status epilepticus, motor deficit, shortage of speech and language, cognitive disorders. The MRI showed multiple areas of cerebral ischemia located in the left hemisphere. The laboratory tests highlightedlactic acidosis, coagulation abnormalities and central nervous system and cardiovascular system damage. The echocardiographic examination revealed cardiomyopathy. Thus the diagnosis of MELAS syndrome was made.The second patient presented the following clinical manifestations: headache, cognitive dysfunction, hemiplegia. The brain MRI showed multiple areas of ischemia.The laboratory analysis revealed anaemia, increased ofacute phase reactants, increased titers of antinuclear antibodies, increased titers of anticardiolipin IgM and IgG antibodies and elevated titer of IgM and IgG antiphospholipid antibodies. The clinical diagnosis of systemic lupus erythematosus (SLE) was established. Conclusions These results suggest that stroke may be the initial manifestation of other severe disease (in our case – mitochondrial disorder, MELAS syndrome and autoimmune disease, SLE). In children, multiple brain structures are involved,at the very onset the clinical symptoms are generalised, nonspecific and polymorphous. Nevertheless, in teenagers, brain nonatheroscleroticvasculopathies are more likely to be responsible for developing of stroke and the clinical syndrome correlates with focal neurological deficits.

6 November 2019 in Biological Markers in Fundamental and Clinical Medicine (collection of abstracts)
Verified
Journal Article
Open access
PDF file
SHS. Hadjiu
S. Hadjiu
MSM. Sprincean
M. Sprincean
CCCornelia Calcii
Cornelia Calcii
NLN. Lupusor
N. Lupusor
CGCorina Griu
Corina Griu
NRNinel Revenco
Ninel Revenco
CILIARY NEUROTROPHIC FACTOR IN PATIENTS WITH PEDIATRIC ISCHEMIC STROKE

6 November 2019 in Biological Markers in Fundamental and Clinical Medicine (collection of abstracts)
Verified
Journal Article
Open access
PDF file
SRS. Racoviţă
S. Racoviţă
VMV. Moşin
V. Moşin
MSM. Sprincean
M. Sprincean
MOLECULAR BIOMARKER OF Y CHROMOSOME AND CFTR GENE IN INFERTILE MALES